Global Recombinant Human Insulin Industry 2015 Deep Market Research Report is a professional and depth research report on Global Recombinant Human Insulin industry.
For overview analysis, the report introduces Recombinant Human Insulin basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc.
For international and China market analysis, the report analyzes Recombinant Human Insulin markets in China and other countries or regions (such as US, Russia, etc.) by presenting research on global products of different types and applications, developments and trends of market, technology, and competitive landscape, and leading suppliers and countries’ 2009-2014 capacity, production, cost, price, profit, production value, and gross margin. For leading suppliers, related information is listed as products, customers, application, capacity, market position, and company contact information, etc. 2015-2020 forecast on capacity, production, cost, price, profit, production value, and gross margin for these markets are also included.
For technical data and manufacturing plants analysis, the report analyzes Recombinant Human Insulin leading suppliers on capacity, commercial production date, manufacturing plants distribution, R&D Status, technology sources, and raw materials sources.
This report also presents product specification, manufacturing process, and product cost structure etc. Production is separated by regions, technology and applications. Analysis also covers upstream raw materials, equipment, downstream client survey, marketing channels, industry development trend and proposals.
In the end, the report includes Recombinant Human Insulin new project SWOT analysis, investment feasibility analysis, investment return analysis, and development trend analysis. In conclusion, it is a deep research report on Global Recombinant Human Insulin industry. Here, we express our thanks for the support and assistance from Recombinant Human Insulin industry chain related technical experts and marketing engineers during Research Team’s survey and interviews.
Chapter One Recombinant Human Insulin Industry Overview 1
1.1 Recombinant Human Insulin Definition 1
1.2 Recombinant Human Insulin Classification 2
1.3 Recombinant Human Insulin Industry Chain Structure 2
1.4 Recombinant Human Insulin Industry Overview 2
1.5 Recombinant Human Insulin Industry Policy Analysis 3
1.6 Recombinant Human Insulin Industry News Analysis 5
Chapter Two Recombinant Human Insulin International and China Market Analysis 7
2.1 Recombinant Human Insulin Industry International Market Analysis 7
2.1.1 Recombinant Human Insulin International Market Development History 7
2.1.2 Recombinant Human Insulin Product and Technology Developments 7
2.1.3 Recombinant Human Insulin International Competitive Landscape Analysis 9
2.1.4 Recombinant Human Insulin International Key Countries Development Status 10
2.1.5 Recombinant Human Insulin International Market Development Trend 11
2.2 Recombinant Human Insulin Industry China Market Analysis 11
2.2.1 Recombinant Human Insulin China Market Development History 11
2.2.2 Recombinant Human Insulin Product and Technology Developments 12
2.2.3 Recombinant Human Insulin China Competitive Landscape Analysis 13
2.2.4 Recombinant Human Insulin China Key Regions Development Status 14
2.2.5 Recombinant Human Insulin China Market Development Trend 15
2.3 Recombinant Human Insulin International and China Market Comparison Analysis 15
Chapter Three Recombinant Human Insulin Technical Data and Manufacturing Plants Analysis 16
3.1 2014 Global Key Insulin Manufacturing Plants Capacity and Commercial Production 16
3.2 2014 Global Key Manufacturers Recombinant Human Insulin Raw Materials Sources Analysis 16
Chapter Four Recombinant Human Insulin Major Countries Import Export Consumption 18
4.1 2009-2014 China Recombinant Human Insulin Supply Import Export Consumption 18
4.2 2009-2014 India Recombinant Human Insulin Supply Import Export Consumption 18
4.3 2009-2014 USA Recombinant Human Insulin Supply Import Export Consumption 19
4.4 2009-2014 France Recombinant Human Insulin Supply Import Export Consumption 19
4.5 2009-2014 Brazil Recombinant Human Insulin Supply Import Export Consumption 19
4.6 2009-2014 Russia Recombinant Human Insulin Supply Import Export Consumption 20
Chapter Five Recombinant Human Insulin Manufacturing Process and Cost Structure 21
5.1 Recombinant Human Insulin Product Specifications 21
5.1.1 Novo Nordisk Recombinant Human Insulin Product Specifications 21
5.1.2 Lilly Recombinant Human Insulin Product Specifications 22
5.2 Recombinant Human Insulin Manufacturing Process Analysis 22
5.3 Recombinant Human Insulin Cost Structure Analysis 23
5.4 Recombinant Human Insulin Cost Analysis 24
Chapter Six 2009-2014 Recombinant Human Insulin Productions Supply Sales Demand Market Status and Forecast 25
6.1 2009-2014 Recombinant Human Insulin Capacity Production (Million Pcs) Overview 25
6.2 2009-2014 Recombinant Human Insulin Production Market Share Analysis 32
6.3 2009-2014 Recombinant Human Insulin Demand Overview 43
6.4 2009-2014 Recombinant Human Insulin Supply Demand and Shortage 45
6.5 2009-2014 Recombinant Human Insulin Import Export Consumption 45
6.6 2009-2014 Recombinant Human Insulin Cost Price Production Value Gross Margin 46
Chapter Seven Recombinant Human Insulin Key Manufacturers Analysis 47
7.1 Novo Nordisk 47
7.1.1 Company Profile 47
7.1.2 Novo Nordisk Recombinant Human Insulin Product Picture and Specification 50
7.1.3 Novo Nordisk Recombinant Human Insulin Capacity Production Price Cost Production Value 50
7.1.4 Contact Information 51
7.2 Eli Lilly 52
7.2.1 Company Profile 52
7.2.2 Eli Lilly Recombinant Human Insulin Product Picture and Specification 55
7.2.3 Eli Lilly Recombinant Human Insulin Capacity Production Price Cost Production Value 56
7.2.4 Contact Information 57
7.3 Bioton 59
7.3.1 Company Profile 59
7.3.2 Bioton Recombinant Human Insulin Product Picture and Specification 59
7.3.3 Bioton Recombinant Human Insulin Capacity Production Price Cost Production Value 62
7.3.4 Contact Information 63
7.4 Dongbao 64
7.4.1 Company Profile 64
7.4.2 Dongbao Recombinant Human Insulin Product Picture and Specification 65
7.4.3 Dongbao Recombinant Human Insulin Capacity Production Price Cost Production Value 68
7.4.4 Contact Information 69
7.5 United Laboratories (TUL) 69
7.5.1 Company Profile 69
7.5.2 United Laboratories Recombinant Human Insulin Product Picture and Specification 73
7.5.3 United Laboratories Recombinant Human Insulin Capacity Production Price Cost Production Value 75
7.5.4 Contact Information 76
Chapter Eight Up and Down Stream Industry Analysis 78
8.1 Upstream Raw Materials Price Analysis 78
8.2 Upstream Equipment Market Analysis 78
8.3 Down Stream Demand Analysis 80
8.4 Industry Chain Analysis 81
Chapter Nine Recombinant Human Insulin Marketing Channels Analysis 82
9.1 Recombinant Human Insulin Marketing Channels Status 82
9.2 Recombinant Human Insulin Marketing Channels Characteristic 82
9.3 Recombinant Human Insulin Marketing Channels Development Trend 83
Chapter Ten Recombinant Human Insulin Industry Development Trend 88
10.1 2015-2020 Recombinant Human Insulin Capacity Production Overview 88
10.2 2015-2020 Recombinant Human Insulin Production Market Share Analysis 90
10.3 2015-2020 Recombinant Human Insulin Demand Overview 94
10.4 2015-2020 Recombinant Human Insulin Supply Demand and Shortage 95
10.5 2015-2020 Recombinant Human Insulin Import Export Consumption 95
10.6 2015-2020 Recombinant Human Insulin Cost Price Production Value Gross Margin 96
Chapter Eleven Recombinant Human Insulin Industry Development Proposals 97
11.1 Macroeconomic Development Countermeasures 97
11.1.1 Macroeconomic policy 98
11.1.2 Specific control measures 99
11.2 New Firms Enter Market Strategy 100
11.3 New Project Investment Proposals 102
11.4 Marketing Channel Strategy Proposals 103
11.5 Competitive Environment Strategy Proposals 104
Chapter Twelve Recombinant Human Insulin New Project Investment Feasibility Analysis 105
12.1 Recombinant Human Insulin Project SWOT Analysis 105
12.2 Recombinant Human Insulin New Project Investment Feasibility Analysis 105
12.2.1 Project Name 105
12.2.2 Investment Budget 105
12.2.3 Project Schedule 106
12.2.4 Benefit Analysis of Project 106
Chapter Thirteen Global and China Recombinant Human Insulin Industry Research Conclusions 108
List of Tables and Figures
Figure Recombinant Human Insulin product picture 1
Table Recombinant Human Insulin Classification 2
Figure Recombinant Human Insulin Industry Chain Structure 2
Figure 2013 International Recombinant Human Insulin Major Manufacturers Production Share 9
Figure 2013 Recombinant Human Insulin International Key Countries Production Share 10
Figure 2015-2020 Recombinant Human Insulin International Capacity Production and Growth Rate 11
Figure 2013 Recombinant Human Insulin China Key Regions Production Share 13
Figure 2013 Recombinant Human Insulin China Key Regions Production Share 14
Figure 2015-2020 Recombinant Human Insulin China Capacity Production and Growth Rate 15
Figure 2009-2014 International and China Capacity Production Comparison 15
Table 2014 Global Key Insulin Manufacturing Plants Capacity and Commercial Production (Million Pcs) Date 16
Table 2014 Global Key Manufacturers Recombinant Human Insulin Raw Materials Sources List 16
Table 2009-2014 China Recombinant Human Insulin Supply Import Export Consumption (Million Pcs) 18
Table 2009-2014 India Supply Import Export Consumption (Million Pcs) 18
Table 2009-2014 USA Recombinant Human Insulin Supply Import Export Consumption (Million Pcs) 19
Table 2009-2014 France Recombinant Human Insulin Supply Import Export Consumption (Million Pcs) 19
Table 2009-2014 Brazil Recombinant Human Insulin Supply Import Export Consumption (Million Pcs) 19
Table 2009-2014 Russia Recombinant Human Insulin Supply Import Export Consumption (Million Pcs) 20
Figure Recombinant Human Insulin Manufacturing Process 23
Figure Recombinant Human Insulin Cost Structure Analysis 24
Figure Recombinant Human Insulin Cost Analysis 24
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Capacity and Total Capacity (Million Pcs) List 25
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Capacity Market Share List 25
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Production and Total Production (Million Pcs) List 26
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Production Market Share List 26
Table 2009-2014 Global Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate 26
Table 2009-2014 Global Recombinant Human Insulin Capacity Utilization Rate List 26
Figure 2009-2014 Global Recombinant Human Insulin Capacity (Million Pcs) and Production Growth Rate 27
Figure 2009-2014 Global Recombinant Human Insulin Capacity Utilization Rate 27
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Capacity and Total Capacity (Million Pcs) List 27
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Capacity Market Share List 28
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Production and Total Production (Million Pcs) List 28
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Production Market Share List 28
Table 2009-2014 China Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate 29
Table 2009-2014 China Recombinant Human Insulin Capacity Utilization Rate List 29
Figure 2009-2014 China Recombinant Human Insulin Capacity and Production Growth Rate 29
Figure 2009-2014 China Recombinant Human Insulin Capacity Utilization Rate 30
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Production Value (Million $) and Total Production Value List 30
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Production Value Market 30
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Production Value (Million $) and Total Production Value List 31
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Production Value Market Share List 31
Figure 2009 Global Major Manufacturers Recombinant Human Insulin Production Market Share 32
Figure 2009 China Major Manufacturers Recombinant Human Insulin Production Market Share 33
Figure 2010 Global Major Manufacturers Recombinant Human Insulin Production Market Share 34
Figure 2010 China Major Manufacturers Recombinant Human Insulin Production Market Share 35
Figure 2011 Global Major Manufacturers Recombinant Human Insulin Production Market Share 36
Figure 2011 China Major Manufacturers Recombinant Human Insulin Production Market Share 37
Figure 2012 Global Major Manufacturers Recombinant Human Insulin Production Market Share 38
Figure 2012 China Major Manufacturers Recombinant Human Insulin Production Market Share 39
Figure 2013 Global Major Manufacturers Recombinant Human Insulin Production Market Share 40
Figure 2013 China Major Manufacturers Recombinant Human Insulin Production Market Share 41
Figure 2014 Global Major Manufacturers Recombinant Human Insulin Production Market Share 42
Figure 2014 China Major Manufacturers Recombinant Human Insulin Production Market Share 43
Table 2009-2014 Global Recombinant Human Insulin Demand (Million Pcs) List 43
Figure 2009-2014 Global Recombinant Human Insulin Demand (Million Pcs) and Growth Rate 44
Table 2009-2014 China Recombinant Human Insulin Demand (Million Pcs) List 44
Figure 2009-2014 China Recombinant Human Insulin Demand (Million Pcs) and Growth Rate 44
Table 2009-2014 Global Recombinant Human Insulin Demand Supply Shortage (Million Pcs) List 45
Table 2009-2014 China Recombinant Human Insulin Demand Supply Shortage (Million Pcs) List 45
Table 2009-2014 China Recombinant Human Insulin Import Export Consumption (Million Pcs) 45
Table 2009-2014 Global Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List 46
Table 2009-2014 China Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List 46
Figure Novo Nordisk Network 48
Figure Novo Nordisk works with five strategic focus areas based on five core capabilities 48
Figure Global manufacturing setup 49
Figure Novo Nordisk’s position is protected by patents and value chain setup 49
Figure Novo Nordisk Recombinant Human Insulin Product Picture and Specification 50
Table 2009-2014 Novo Nordisk Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List 50
Figure 2009-2014 Novo Nordisk Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate 51
Figure 2009-2014 Novo Nordisk Recombinant Human Insulin Production Global Market Share 51
Figure Eli Lilly Recombinant Human Insulin Product Picture and Specification 56
Table 2009-2014 Eli Lilly Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List 56
Figure 2009-2014 Eli Lilly Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate 57
Figure 2009-2014 Eli Lilly Recombinant Human Insulin Production Global Market Share 57
Figure Bioton Million Pcs Gensulin M30 Recombinant Human Insulin Product Picture and Specification 61
Table 2009-2014 Bioton Million Pcs Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List 62
Figure 2009-2014 Bioton Million Pcs Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate 62
Figure 2009-2014 Bioton Recombinant Human Insulin Production Global Market Share 63
Figure Dongbao Gansulin R Recombinant Human Insulin Product Picture and Specification 65
Figure Dongbao Gansulin N Recombinant Human Insulin Product Picture and Specification 66
Figure Dongbao Gansulin 30R Recombinant Human Insulin Product Picture and Specification 67
Table 2009-2014 Dongbao Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List 68
Figure 2009-2014 Dongbao Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate 68
Figure 2009-2014 Dongbao Recombinant Human Insulin Production Global Market Share 69
Figure United Laboratories USLIN® N Recombinant Human Insulin Product Picture and Specification 73
Figure United Laboratories USLIN®50 Recombinant Human Insulin Product Picture and Specification 73
Figure United Laboratories USLIN®30 Recombinant Human Insulin Product Picture and Specification 74
Figure United Laboratories USLIN®R Recombinant Human Insulin Product Picture and Specification 74
Table 2009-2014 United Laboratories Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List 75
Figure 2009-2014 United Laboratories Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate 75
Figure 2009-2014 United Laboratories Recombinant Human Insulin Production Global Market Share 76
Figure Fermenter Picture 78
Figure Extraction system and Separation equipment 79
Figure Air purification systems 80
Figure Cold storage 80
Table 2009-2014 the Number of Diabetes (Million) and Diabetes Required Recombinant Human Insulin (Million) and Diabetes Growth Rate 81
Figure Recombinant Human Insulin Industry Chain 81
Figure Recombinant Human Insulin Marketing Channels Status 82
Table Recombinant Human Insulin Marketing Channels Characteristic Overview 82
Figure Marketing Channels Characteristic 83
Figure Flat Sales Channel Forms a Glance 84
Figure Partnership-type Relationship Sales Channels Form a Glance 86
Figure the export trend Overview 86
Figure 2015-2020 Global Recombinant Human Insulin Capacity (Million Pcs) Production (Million Pcs) and Growth Rate 88
Figure 2015-2020 China Recombinant Human Insulin Capacity (Million Pcs) Production (Million Pcs) and Growth Rate 89
Figure 2015 Global Recombinant Human Insulin Production Market Share 90
Figure 2020 Global Recombinant Human Insulin Production Market Share 91
Figure 2015 China Recombinant Human Insulin Production Market Share 92
Figure 2020 China Recombinant Human Insulin Production Market Share 93
Figure 2015-2020 Global Recombinant Human Insulin Demand (Million Pcs) and Growth Rate 94
Figure 2015-2020 China Recombinant Human Insulin Demand (Million Pcs) and Growth Rate 94
Table 2015-2020 Global Recombinant Human Insulin Demand (Million Pcs) Supply (Million Pcs) Shortage (Million Pcs) List 95
Table 2015-2020 China Recombinant Human Insulin Demand (Million Pcs) Supply (Million Pcs) Shortage (Million Pcs) List 95
Table 2015-2020 China Recombinant Human Insulin Import (Million Pcs) Export (Million Pcs) Consumption (Million Pcs) 95
Table 2015-2020 Global Recombinant Human Insulin Capacity (Million Pcs) Production (Million Pcs) Price ($/Pcs) Cost ($/Pcs) Gross ($/Pcs) Production Value (Million $) Gross Margin List 96
Table 2015-2020 China Recombinant Human Insulin Capacity (Million Pcs) Production (Million Pcs) Price ($/Pcs) Cost ($/Pcs) Gross ($/Pcs) Production Value (Million $) Gross Margin List 96
Table Macroeconomic Development Countermeasures Analysis 97
Table New Firms Enter Market Strategy 100
Table New Project Investment Proposals 102
Figure Recombinant Human Insulin Marketing strategy recommendations 103
Table Recombinant Human Insulin Marketing Channel Strategy Proposals 104
Table Competitive Environment Strategy Proposals 104
Table Recombinant Human Insulin Project SWOT Analysis 105
Table 100 Million Pcs Recombinant Human Insulin Project Appraisal and Financing 106
Table 100 Million Pcs Recombinant Human Insulin Project Construction Period 106
Table Annual Output of 100 Million Pcs Recombinant Human Insulin Project Return on Investment and Feasibility Analysis 106
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : November 2019
$ 3600
Published On : November 2019
$ 3600
Published On : November 2019
$ 3600
$ 3950
Published On : April 2019
$ 3000
